Stocks making the biggest moves after hours: Novavax, Upstart, Allbirds and more

Finance

A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020.
Dado Ruvic | Reuters

Check out the companies making headlines after hours.

Novavax — The biotech stock dropped 32% after Novavax cut its full-year revenue guidance due to poor demand for its Covid vaccines.

Take-Two Interactive Software — Shares dropped 6% after the video game company behind titles such as Grand Theft Auto reported weaker-than-expected earnings. Take-Two reported $1 billion in revenue, less than the $1.09 billion projected by analysts surveyed by Refinitiv.

Upstart — Shares fell 7% after the consumer lending company posted disappointing second quarter results. Upstart earned 1 cent per share on revenue of $228.2 million. Analysts surveyed by Refinitiv were estimating earnings of 10 cents per share on revenue of $241.6 million.

Allbirds — The footwear stock dropped 12% after Allbirds cut its outlook for the year and announced cost-cutting efforts, citing weaker consumer spending. The footwear and apparel company otherwise beat expectations in its second-quarter results, compared with consensus estimates from Refinitiv.

Hims & Hers Health — Shares gained more than 4% after the telehealth company reported quarterly results and raised its full year outlook, citing continued momentum in the number of net new subscriptions.

Products You May Like

Articles You May Like

Everything parents need to know about student loan forgiveness
How Bryan Lourd became one of the most powerful people in the history of Hollywood
Pairing up? Here’s how to know when it’s time to combine your finances
Boeing to pay $200 million to settle charges over misleading investors after 737 Max crashes
Mark Zuckerberg: The metaverse will unfold in 3 steps, and one is happening ‘sooner than I thought’

Leave a Reply

Your email address will not be published.